Adamed Pharma S.a. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Adamed Pharma S.a.

Patent Number:
Title:
Tablets Comprising Tamsulosin And Solifenacin
Applicant:
Opposition Date:
Aug 9, 2024
Patent Number:
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
Opposition Date:
Jul 11, 2023

Latest patents of Adamed Pharma S.a. opposed by its competitors

Patent:
Grant Date:
Sep 6, 2017
Title:
A Pharmaceutical Composition Containing An Ace Inhibitor And A Calcium Channel Blocker
Oppositions:
1

Competitors of Adamed Pharma S.a.

HOFFMANN EITLE

NOVARTIS AG

SYNTHON B.V.

Want to track Adamed Pharma S.a.?

Feel free to send us a message here and we will get back to you